Leadership · 4 min read
OrthoGlobe: Building the Collaborative Infrastructure That Global Orthopaedics Needs
The evidence that guides orthopaedic practice worldwide is generated predominantly in a small number of well-resourced centres in high-income countries, in patient populations that represent a fraction of the global disease burden. OrthoGlobe was founded on the conviction that this can change — and that the technology and the will to change it are both available, right now, to those who choose to act.
Global musculoskeletal disease is one of the leading causes of disability worldwide, affecting people across every age group, every economic setting, and every geographic region. Yet the research infrastructure that produces the evidence base for orthopaedic management is concentrated in a remarkably small number of academic centres — predominantly in North America, the UK, Scandinavia, and Germany — that collectively represent a fraction of the world's musculoskeletal disease burden. The consequence is a clinical evidence base that is less diverse, less generalisable, and less equitable than the patients it is designed to serve deserve.
What OrthoGlobe is building
OrthoGlobe is a federated global research network designed to address this inequity directly. The architecture is federated — data stays at each participating site, model parameters rather than patient records are shared — allowing institutions in any healthcare setting to contribute to collective evidence generation without the data sovereignty concerns that have historically made international data pooling impractical. Common data models, harmonised outcome measures, and shared analytical protocols allow like-for-like comparison across sites that would otherwise be incomparable.
The network's fairness infrastructure — performance dashboards stratified by age, sex, ethnicity, and socioeconomic indicators — ensures that the evidence produced serves the full diversity of the patients who contribute to it. A model that performs well on average but systematically underperforms for specific demographic groups has not met the equity standard that OrthoGlobe holds as foundational.
The collaborative model as the future of orthopaedic research
The single-centre study — the dominant unit of orthopaedic research for decades — is approaching the limits of what it can contribute to the questions that matter most in clinical practice. The questions that most need answering — which implant systems perform best across the full diversity of patient anatomies and bone qualities; which rehabilitation protocols produce the best outcomes in different health system contexts; which risk factors most reliably predict surgical complications across demographic groups — require the statistical power and demographic diversity that only multicentre, multinational collaboration can provide.
The future of orthopaedic research is not competitive — it is collaborative. The institutions that contribute to shared evidence generation will produce findings that serve their patients and the world's patients simultaneously.
Participation in OrthoGlobe is open to any institution committed to the network's standards of data quality, ethical oversight, and equity in both research design and benefit sharing. The barriers to entry are designed to be as low as possible — because every site that joins brings patients who deserve to contribute to and benefit from a global evidence base, and every research question that is answered collaboratively is one that individual centres could not have answered alone.
💬 If you are involved in orthopaedic research, what would make participation in a global federated network genuinely valuable for your institution — and what barriers would need to be removed?